In this HNSCC cohort, we observed that positive PD-L1 expression was significantly associated with higher DSS rates, especially when expression was measured in both tumor and immune cells (CPS) and in cases definitively treated with CRT. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.